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103e9.Identification and Characterization of
a Recessive Missense Mutation p.P277L
in SERPINB7 in Nagashima-Type
Palmoplantar Keratosis
Journal of Investigative Dermatology (2016) 136, 325e328; doi:10.1038/JID.2015.347TO THE EDITOR
Hereditary palmoplantar keratodermas
are a heterogeneous group of keratini-
zation disorders characterized by hy-
perkeratosis of the palms and soles with
or without other ectodermal abnor-
malities. Nagashima-type palmoplantar
keratosis (NPPK; MIM 615598) is a
recently established autosomal reces-
sive palmoplantar keratoderma caused
by mutations in the gene encoding
SERPINB7, a member of the serineprotease inhibitor superfamily (Kubo,
2014; Kubo et al., 2013). NPPK is
characterized by a well-demarcated
reddish, diffuse, and mild non-
epidermolytic palmoplantar kerato-
derma extending to the dorsal surface
of the hands and feet, inner wrists, and
Achilles tendon area. To date, a highly
prevalent mutation of c.796C>T
(rs142859678; p.R266*) has been re-
ported in 39 of 46 alleles of Japanese
individuals with NPPK, and in 10 of14 alleles of Chinese individuals with
NPPK (Kubo et al., 2013; Mizuno et al.,
2014; Yin et al., 2014). The c.796C>T
mutation was found only among Japa-
nese and Chinese populations but not
Western and African populations in the
1000 Genomes project database (Kubo
et al., 2013). Single nucleotide poly-
morphisms (SNPs) observed within the
SERPINB7 genomic lesion were iden-
tical for the c.796C>T allele in the
Chinese population (Yin et al., 2014),
suggesting a founder effect of the
mutation.
SERPINB7 is expressed in the stratum
granulosum and stratum corneum. Towww.jidonline.org 325
Figure 1. Phenotype, genotype, and geographic origins of the NPPK individuals and their families. (a)
Reddish hyperkeratosis of hands and feet extending to the dorsal surfaces of the fingers, toes, and to the
Achilles tendon area. (b) Immunohistochemistry of control and patient stratum corneum with anti-
SERPINB7 antibody. Bar: 100 mm. (c) Family trees with mutational status in NPPK families 1e5. (d)
Immunoblot analysis of His-tagged wild-type and p.P277L mutant SERPINB7 expressed in baculovirus-
infected silkworm. Arrows: recombinant SERPINB7. (e) The region of origin of the c.830C>T mutation
carriers in this study. NPPK, Nagashima-type palmoplantar keratosis.
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326date, all of the reported mutations of
SERPINB7 in patients with NPPK were
nonsense, frame shift, or splice-site
mutations (Kubo et al., 2013; Mizuno
et al., 2014; Yin et al., 2014), resulting
in loss of the reactive site loop, critical
for protease inhibitory activity (Gettins,
2002; Kubo et al., 2013). Here, we
report a recessive missense mutation
of SERPINB7 in typical patients with
NPPK resulting in SERPINB7 mis-
localization to intracellular aggregates.Journal of Investigative Dermatology (2016), VolumImmunohistochemistry with anti-
SERPINB7 antibody (HPA024200;
Sigma-Aldrich, St. Louis, MO) showed
complete loss of SERPINB7 staining in
previously reported patients with NPPK
(Kubo et al., 2013). We found two
patients (KDex40 and KDex63) who
exhibited typical NPPK phenotypes
(Figure 1a) but revealed SERPINB7-
positive aggregates within corneocytes
with no SERPINB7 signals at the cell
periphery, whereas SERPINB7 signalse 136were localized at the cell periphery
of corneocytes in healthy controls
(Figure 1b). SERPINB7 was sequenced
from genomic DNA of the patients’
peripheral blood leukocytes, after writ-
ten informed consent and approval
by the Institutional Review Board. The
patients were found to be compound
heterozygotes of a missense mutation
of SERPINB7, c.830C>T (p.P277L),
with recurrent mutations of c.796C>T
(p.R266*) (Figure 1c, Supplementary
Figure S1a online). The failure to
detect the p.R266* mutant by immu-
nohistochemistry using the antibody
(Kubo et al., 2013) suggested that the
p.P277L mutant was localized to the
aggregates.
Homology alignment revealed that
proline residue 277 of human SERPINB7,
which is changed to leucine by the
c.830C>T mutation, is completely
conserved, not only among the 13
members of the clade B human SERPINs
but also in mammalian orthologs of
SERPINB7 (Supplementary Figure S1b
online). We produced His-tagged re-
combinant wild-type and p.P277L
mutant SERPINB7 in silkworm (Bombyx
mori) using baculovirus infection
(Motohashi et al., 2005). The total
homogenate of the baculovirus-infected
silkworm was fractionated by centrifu-
gation, and immunoblotting was per-
formed using anti-His-tag antibody
(His-probe, GE Healthcare, Little Chal-
font, UK). A significant amount of re-
combinant wild-type SERPINB7 was
soluble, was purified via the Ni-
Sepharose column (Figure 1d), and
showed plasmin inhibitor activity in the
assay described previously (data not
shown; Miyata et al., 2002), whereas
His-tagged p.P277L mutant was detec-
ted mainly in the precipitate, not the
soluble supernatant (Figure 1d). Affinity
purification of the p.P277L mutant from
the supernatant via the Ni-Sepharose
column failed to concentrate any
soluble SERPINB7, suggesting that the
majority of the p.P277L mutant protein
was insoluble and therefore formed
intracellular aggregates in the patients’
skin.
We screened the c.830C>T muta-
tion in our patients with NPPK
and identified another four patients
carrying the same mutation in
a compound heterozygous manner
(Figure 1c) with recurrent mutations of
Table 1. Haplotype analysis of wild-type alleles and pathogenic mutant alleles of SERPINB7 in the
Japanese population
SERPINB7
cDNA location Genomic location SNP ID
Wild-type alleles in the
Japanese population Pathogenic mutant alleles
Allele
A
Allele
B
Allele
C
Allele
D
c.830C>T
p.P277L
c.218_219del2ins12
p.Q73L fs*17
c.796C>T
p.R266*
c.455-1G>A
p.G152V fs*21
c.218_219 exon 3 AG AG AG AG AG delAGinsTAAACTTTACCT AG AG
c.455-1 intron 5 G G G G G G G A
c.744þ60 intron 7 rs2689399 G C C C G G G C
c.744þ534 intron 7 rs1720866 A G G G A A A G
c.744þ655 intron 7 rs9967135 C C T T C C C C
c.744þ1257 intron 7 rs1720867 G A G G G G G A
c.744þ1584 intron 7 rs1720868 T C T T T T T C
c.796 exon 8 rs142859678 C C C C C C T C
c.797 exon 8 rs17782413 G G G A G G G G
c.830 exon 8 C C C C T C C C
c.*18 exon 8 (30UTR) rs1625353 G A G G G G G A
c.*586 exon 8 (30UTR) rs1055901 T C C C T T T C
c.*660 exon 8 (30UTR) rs2658460 C T C C C C C T
c.*674 exon 8 (30UTR) rs1055902 C T T T C C C T
18:63808277 rs1701630 A G A A A A A G
18:63808269 rs1506411 G T G G G G G T
Abbreviation: SNP, single nucleotide polymorphism.
Nucleotides that vary from the reference allele (allele A) are underlined, and pathogenic mutations are in bold.
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GinsTAAACTTTACCT (KDex116 and
KDex118, clinically reported previously
by Isoda et al., 2009), or c.455-1G>A
(KDex121, clinically reported previ-
ously by Kabashima et al., 2008).
Because heterozygous carriers of the
c.830C>T mutation (I-1 and II-2 of
family 1, and I-1 of family 4) had no
symptoms of NPPK, the p.P277L mutant
may not affect the protease inhibitory
activity of wild-type SERPINB7.
We employed haplotype analysis to
determine whether the pathogenic
mutations were derived from a com-
mon ancestor or whether they repre-
sented mutation hot spots. We
analyzed five SNPs within SERPINB7
exon 8 (rs17782413, rs1625353,
rs1055901, rs2658460, rs1055902) in
patients with NPPK, their unaffected
relatives, and normal controls, and
identified four wild-type alleles (AeD)
in the Japanese population (Table 1).
The allele frequencies estimated from
the HapMap project database (http://
hapmap.ncbi.nlm.nih.gov/, accessed 15
February 2015) and the Human Genetic
Variation Database (http://www.
genome.med.kyoto-u.ac.jp/SnpDB/about.
html, accessed 15 February 2015)
were as follows: A ¼ 42.2e46.7%;
B ¼ 30%; C ¼ 14e18.5%; D ¼ 9.3%.
The recurrent c.796C>T mutation haspreviously been identified in allele A
for the Chinese population (Yin et al.,
2014). In our study participants, the
c.830C>T mutation (n ¼ 6 alleles)
and the recurrent mutations of
c.796C>T (n ¼ 35 alleles) and
c.218_219delAGinsTAAACTTTACCT
(n ¼ 11 alleles) were all identified
in allele A, whereas the recurrent
c.455-1G>A (n ¼ 8 alleles) mutation
was identified in allele B (Table 1),
suggesting that the c.830C>T
mutation occurred in allele A inde-
pendently from other recurrent muta-
tions. Interestingly, subjects I-1 of
family 1, I-2 of family 3, II-1 and II-2
of family 4, and I-1 of family 5 all
originated from Kyushu Island, Japan
(Figure 1e), suggesting that the
founder mutation of c.830C>T might
have occurred fairly recently relative
to the c.796C>T mutation.
In conclusion, we identified a
missense mutation of SERPINB7 in five
independent Japanese families with
NPPK. The mutated protein formed
aggregates and mislocalized within
corneocytes, possibly resulting in loss
of protease inhibitory activity at the
proper location. The founder effect
of the mutation and other recurrent
mutations may explain why NPPK is so
common in the Japanese population
but not in Western populations.CONFLICT OF INTEREST
The authors state no conflict of interest.
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2269e72.Elevated Galectin-10 Expression of
IL-22-Producing T Cells in Patients
with Atopic Dermatitis
Journal of Investigative Dermatology (2016) 136, 328e331; doi:10.1038/JID.2015.369TO THE EDITOR
Atopic dermatitis (AD) is a highly pru-
ritic, chronic, relapsing skin disease
characterized by typically distributed
skin lesions. Recently, subsets of T cells
including TH1, TH2, TH17, TH22, and
regulatory T (Treg) cells have been
implicated as contributing factors to the
immune dysregulation of AD. In this
study, by using different quantitative
proteomics, we identified differentially
expressed proteins in CD3þ T cells
from patients with AD and healthy
controls (HCs), and found that galectin-
10 was elevated in IL-22-producing
CD4þ T cells in patients with AD.
This study was approved by the
institutional review board, and written
informed consent was obtained from
each patient. A total of 45 patients
with AD and 20 HCs were enrolled
in this study. Diagnosis of AD was
made according to the criteria of
Hanifin and Rajka (1980). Patients
were classified based on their allergic
history, skin prick test, ImmunoCAP
test, and serum IgE (Supplementary
Table S1 online). Detailed methods
were described in the Supplementary
Methods online.To study the differential protein
expression from CD3þ T cells in HCs
and patients with AD, we performed
LC/MS/MS analysis. Quantitative
analysis based on the normalized
spectral index (SIN) of identified pro-
teins (Griffin et al., 2010) resulted in
Supplementary Table S2 online. Among
the total 636 proteins identified, 75 and
81 showed higher expressions of five
times more in CD3þ T cells in patients
with AD and in HCs, respectively.
Extracted ion chromatograms of pep-
tides from galectin-10 and S100A9
increased in patients with AD
(Figure 1a) were presented with their
MS/MS spectra (Supplementary
Figure S1 online), confirmed by west-
ern blot analysis to be highly expressed
in patients with AD (Figure 1b).
Confocal laser microscopy also showed
higher intensities of galectin-10 staining
in CD3þ T cells from patients with AD
compared with HCs (Figure 1c).
As the upregulation of galectin-10
was mainly attributed to CD4þ T cells
(Figure 2a), we performed flow cytom-
etry using CD3þCD4þ T cells in the
following analysis. Galectin-10 was
significantly upregulated in IL-22expressing CD3þCD4þ T cells from
patients with AD compared with HCs
(Figure 2b). There was no significant
difference of galectin-10 expression in
CD3þCD4þ T cells producing other
cytokines such as IL-17, IFN-g, IL-4, or
IL-10 (Figure 2b and Supplementary
Figure S2 online). In the immunohisto-
chemical staining, galectin-10 was
highly expressed in CD3þ T cells in AD
skin, whereas its expression was nearly
undetectable in the normal skin
(Figure 2c). Interestingly, significant
acanthosis was also observed adjacent
to the dermal area where galectin-10þ
CD3þ T cells were present, implying
that epidermal hyperplasia in AD may
result from galectin-10þ T cells pro-
ducing IL-22.
Next, we performed a correlation
study between serum galectin-10 and
various clinical and laboratory vari-
ables (Noh et al., 2014). The serum
galectin-10 were significantly higher
in patients with AD compared with
HCs (Figure 2d, and Supplementary
Table S3 online) showing a positive
correlation between galectin-10 levels
and eczema area and severity index
score (r ¼ 0.409, P ¼ 0.018), and
investigator’s global assessment
(r ¼ 0.553, P ¼ 0.001). No significant
correlation was observed between
serum galectin-10 and cell counts,
